Although the drug requires no CYP2C9 genotyping or first-dose observation, an up-titration scheme should be used due to the risk of transient cardiac conduction issues.
from Front page feed https://ift.tt/3amkLPl
from Front page feed https://ift.tt/3amkLPl
Comments
Post a Comment